Citi analyst Samantha Semenkow lowered the firm’s price target on Wave Life Sciences (WVE) to $24 from $30 and keeps a Buy rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WVE:
- Wave Life Sciences price target lowered to $43 from $52 at Canaccord
- Wave Life Sciences Signals Momentum In Earnings Call
- Wave Life Sciences price target lowered to $19 from $21 at BofA
- Wave Life Sciences assumed with a Buy at Truist
- Wave Life Sciences price target lowered to $36 from $39 at Clear Street